Trimetazidine Controlled Release 35 mg Cardiac Tablet | TRIBLESS-MR 35

₹1,200.00

Modified-release Trimetazidine 35 mg used as add-on therapy for symptomatic treatment of stable angina when appropriate.

Product Specifications

Composition: Trimetazidine (CR) 35mg
Dosage Form: Tablets
Therapeutic Categories: Cardiac / Diabetic Range

Additional information

Product Name

TRIBLESS-MR 35 Tablet

Generic Name

Trimetazidine

Composition

Trimetazidine (CR) 35mg

Dosage Form

Therapeutic Categories

Drug Class

Metabolic anti-anginal agent

Indication

Symptomatic Treatment of Stable Angina

Target Infections - Conditions

Stable Angina Pectoris, Ischemic Heart Disease

Strength

35 mg controlled release

Pack Size

10*10 Tablets

Packaging Type

Alu Alu

Storage Conditions

Store in a cool and dry place below 25?C. Protect from moisture and direct sunlight.

Prescription Status

Rx (To be taken under medical supervision)